Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells
Year: 2013
Type: article
Source: Oncogene
DOI: 10.1038/onc.2013.308
Authors: D Raina, Y Uchida, A Kharbanda, H Rajabi, G Panchamoorthy, C Jin, S Kharbanda, M Scaltriti, J Baselga, D Kufe
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
OpenAlex ID: W2012204343
